MANNKIND CORP (MNKD) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 26, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for MANNKIND CORP?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, MANNKIND CORP's filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-26.85%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Continuing Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does MANNKIND CORP actually do?
Answer:
MannKind Corporation is a biopharmaceutical company focused on developing and commercializing patient-centric therapies for chronic diseases, particularly cardiometabolic and orphan lung conditions. Its commercial portfolio includes Afrezza (inhaled insulin) for diabetes, Furoscix (furosemide injection) for edema, and the V-Go wearable insulin delivery device. The company also has a collaboration with United Therapeutics for Tyvaso DPI, a treatment for pulmonary hypertension, and is developing MNKD-201 for idiopathic pulmonary fibrosis. MannKind leverages its proprietary Technosphere drug delivery platform, which utilizes fumaryl diketopiperazine (FDKP) excipient for pulmonary drug delivery.
Question:
What are MANNKIND CORP's revenue drivers?
Answer:
Revenue is driven by product sales of Afrezza, Furoscix, and V-Go, as well as royalties and manufacturing revenue from its collaboration with United Therapeutics for Tyvaso DPI.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required